Cyclacel Pharmaceuticals, Inc. (CYCC) Starts Presentation at Biotech Showcase Conference

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a recognized leader in the field of tumor suppressor biology, founded the company in 1996. In 1999, Professor David Glover, a recognized leader in the mechanism of mitosis or cell division, also joined the company. For more information, visit the company’s website at www.cyclacel.com.